Cargando…

Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?

Aim. The aim of this study is to evaluate whether leaving the biopsy needle used during prostate needle biopsy in 10% povidone-iodine (betadine) solution affects the infectious complications forming after biopsy. Material and Method. This study retrospectively evaluated the data of 176 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Benli, Erdal, Cirakoglu, Abdullah, Ogreden, Ercan, Cetinkol, Yeliz, Calgin, Mustafa Kerem, Ayyildiz, Ali, Yüce, Ahmet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206407/
https://www.ncbi.nlm.nih.gov/pubmed/28096812
http://dx.doi.org/10.1155/2016/6841837
_version_ 1782490250327621632
author Benli, Erdal
Cirakoglu, Abdullah
Ogreden, Ercan
Cetinkol, Yeliz
Calgin, Mustafa Kerem
Ayyildiz, Ali
Yüce, Ahmet
author_facet Benli, Erdal
Cirakoglu, Abdullah
Ogreden, Ercan
Cetinkol, Yeliz
Calgin, Mustafa Kerem
Ayyildiz, Ali
Yüce, Ahmet
author_sort Benli, Erdal
collection PubMed
description Aim. The aim of this study is to evaluate whether leaving the biopsy needle used during prostate needle biopsy in 10% povidone-iodine (betadine) solution affects the infectious complications forming after biopsy. Material and Method. This study retrospectively evaluated the data of 176 patients with prostate biopsy performed between December 2012 and April 2014. Patients in Group 1 (n = 89) were given ofloxacin as a prophylactic antibiotic before biopsy. Patients in Group 2 (n = 87) had the biopsy needle left in povidone-iodine solution for 1 minute before each use, in addition to antibiotic prophylaxis. The two groups were compared in terms of infective complications developing after biopsy. Results were analyzed using the Mann–Whitney U test and Fisher's exact test. Results. The distribution of infective complications after biopsy according to group was as follows. Group 1, not using betadine, had 15.7% fever, 13.5% hospital stay, 12.4% urinary retention, 10.1% prostatitis, and 5.6% sepsis. The distribution of the same complications in Group 2 using betadine was identified as 5.7% fever, 4.6% hospital stay, 3.4% urinary retention, 2.3% prostatitis, and 0% sepsis. The use of betadine was found to significantly reduce the infectious complications after biopsy compared to the control group (p < 0.05). Conclusion. At the end of this study leaving the prostate needle in povidone-iodine solution before each use during prostate biopsy was found to reduce the infective complications and hospital stay after biopsy.
format Online
Article
Text
id pubmed-5206407
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-52064072017-01-17 Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy? Benli, Erdal Cirakoglu, Abdullah Ogreden, Ercan Cetinkol, Yeliz Calgin, Mustafa Kerem Ayyildiz, Ali Yüce, Ahmet Adv Urol Clinical Study Aim. The aim of this study is to evaluate whether leaving the biopsy needle used during prostate needle biopsy in 10% povidone-iodine (betadine) solution affects the infectious complications forming after biopsy. Material and Method. This study retrospectively evaluated the data of 176 patients with prostate biopsy performed between December 2012 and April 2014. Patients in Group 1 (n = 89) were given ofloxacin as a prophylactic antibiotic before biopsy. Patients in Group 2 (n = 87) had the biopsy needle left in povidone-iodine solution for 1 minute before each use, in addition to antibiotic prophylaxis. The two groups were compared in terms of infective complications developing after biopsy. Results were analyzed using the Mann–Whitney U test and Fisher's exact test. Results. The distribution of infective complications after biopsy according to group was as follows. Group 1, not using betadine, had 15.7% fever, 13.5% hospital stay, 12.4% urinary retention, 10.1% prostatitis, and 5.6% sepsis. The distribution of the same complications in Group 2 using betadine was identified as 5.7% fever, 4.6% hospital stay, 3.4% urinary retention, 2.3% prostatitis, and 0% sepsis. The use of betadine was found to significantly reduce the infectious complications after biopsy compared to the control group (p < 0.05). Conclusion. At the end of this study leaving the prostate needle in povidone-iodine solution before each use during prostate biopsy was found to reduce the infective complications and hospital stay after biopsy. Hindawi Publishing Corporation 2016 2016-12-20 /pmc/articles/PMC5206407/ /pubmed/28096812 http://dx.doi.org/10.1155/2016/6841837 Text en Copyright © 2016 Erdal Benli et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Study
Benli, Erdal
Cirakoglu, Abdullah
Ogreden, Ercan
Cetinkol, Yeliz
Calgin, Mustafa Kerem
Ayyildiz, Ali
Yüce, Ahmet
Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title_full Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title_fullStr Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title_full_unstemmed Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title_short Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?
title_sort does leaving the biopsy needle in povidone-iodine solution reduce infective complications after biopsy?
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5206407/
https://www.ncbi.nlm.nih.gov/pubmed/28096812
http://dx.doi.org/10.1155/2016/6841837
work_keys_str_mv AT benlierdal doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT cirakogluabdullah doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT ogredenercan doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT cetinkolyeliz doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT calginmustafakerem doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT ayyildizali doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy
AT yuceahmet doesleavingthebiopsyneedleinpovidoneiodinesolutionreduceinfectivecomplicationsafterbiopsy